The Food and Drug Administration (FDA) has approved the first needle-free treatment for the life-threatening allergic reaction anaphylaxis.
In a statement released Friday (Aug. 9), the FDA announced it had approved Neffy, a nasal-spray formulation of epinephrine. That's the same medication found in EpiPens.
